Animal models of stomach carcinogenesis

Toxicologic Pathology

Volumn 35, Issue 5, 2007, Pages 636-648

  Tsukamoto, Tetsuya ^a   Mizoshita, Tsutomu ^a   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Animal model; Gastric; Helicobacter pylori; Intestinal metaplasia; Mongolian gerbil; Mouse; Rat

Indexed keywords

CANCER GROWTH; CARCINOGENESIS; CHEMOPROPHYLAXIS; CHRONIC INFLAMMATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; INTESTINE METAPLASIA; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOGENESIS; STOMACH LESION;

ANIMALS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; HUMANS; METAPLASIA; PRECANCEROUS CONDITIONS; SODIUM CHLORIDE, DIETARY; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; HELICOBACTER PYLORI; MERIONES UNGUICULATUS; MUS; RATTUS;

EID: 34547168840     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230701420632     Document Type: Review

References (133)

1. Almeida, R., Silva, E., Santos-Silva, F., Silberg, D. G., Wang, J., De Bolos, C., and David, L. (2003). Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 199, 36-40.
2. Asaka, M., Kato, M., Kudo, M., Katagiri, M., Nishikawa, K., Koshiyama, H., Takeda, H., Yoshida, J., and Graham, D. Y. (1996). Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1, 52-6.
3. Asaka, M., Kimura, T., Kudo, M., Takeda, H., Mitani, S., Miyazaki, T., Miki, K., and Graham, D. Y. (1992). Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102, 760-6.
4. Bamba, M., Sugihara, H., Kushima, R., Okada, K., Tsukashita, S., Horinouchi, M., and Hattori, T. (2001). Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch 438, 49-56.
5. Cao, X., Tsukamoto, T., Nozaki, K., Mizoshita, T., Ogasawara, N., Tanaka, H., Takenaka, Y., Kaminishi, M., and Tatematsu, M. (2004). Beta-catenin gene alteration in glandular stomach adenocarcinomas in N-methyl-N-nitrosourea- treated and Helicobacter pylori-infected Mongolian gerbils. Cancer Sci. 95, 487-90.
6. Cao, X., Tsukamoto, T., Nozaki, K., Tanaka, H., Shimizu, N., Kaminishi, M., Kumagai, T., and Tatematsu, M. (2002). Earlier Helicobacter pylori Infection increases the risk for the N-methyl-N-nitrosourea-induced stomach carcinogenesis in Mongolian gerbils. Jpn. J. Cancer Res. 93, 1293-8.
7. Correa, P. (1992). Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52, 6735-40.
8. Correa, P., Fontham, E. T., Bravo, J. C., Bravo, L. E., Ruiz, B., Zarama, G., Realpe, J. L., Malcom, G. T., Li, D., Johnson, W. D., and Mera, R. (2000). Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92, 1881-8.
9. Craanen, M. E., Dekker, W., Blok, P., Ferwerda, J., and Tytgat, G. N. (1992). Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 33, 16-20.
10. Crew, K. D., and Neugut, A. I. (2004). Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31, 450-64.
11. Eda, A., Osawa, H., Yanaka, I., Satoh, K., Mutoh, H., Kihira, K., and Sugano, K. (2002). Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 37, 94-100.
12. Faller, G., and Kirchner, T. (2005). Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 446, 1-9.
13. Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., and Sitas, F. (1991). Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302, 1302-5.
14. Fox, J. G., Li, X., Cahill, R. J., Andrutis, K., Rustgi, A. K., Odze, R., and Wang, T. C. (1996). Hypertrophic gastropathy in Helicobacter felis-infected wildtype C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 110, 155-66.
15. Furihata, C., Iwasaki, Y., Sugimura, T., Tatematsu, M., and Takahashi, M. (1973). Differentiation of pepsinogen-producing cells in the fundic and pyloric mucosa of developing rats. Cell Differ 2, 179-89.
16. Furihata, C., Ohta, H., and Katsuyama, T. (1996). Cause and effect between concentration-dependent tissue damage and temporary cell proliferation in rat stomach mucosa by NaCl, a stomach tumor promoter. Carcinogenesis 17, 401-6.
17. Furihata, C., Saito, D., Fujiki, H., Kanai, Y., Matsushima, T., and Sugimura, T. (1980). Purification and characterization of pepsinogens and a unique pepsin from rat stomach. Eur J Biochem 105, 43-50.
18. Furihata, C., Sasajima, K., Kazama, S., Kogure, K., Kawachi, T., Sugimura T., Tatematsu, M., and Takahashi, M. (1975). Changes in pepsinogen isozymes in stomach carcinogenesis induced in rats by N-methyl-N′-nitro-N- nitrosoguanidine. J Natl Cancer Inst 55, 925-30.
19. Furihata, C., Tatematsu, M., Saito, M., Ishida, S., Nakanishi, H., Inada, K., Tei, H., Hattori, M., Ito, T., and Sakaki, Y. (1997). Rare occurrence of ras and p53 gene mutations in mouse stomach tumors induced by N-methyl-N-nitrosourea. Jpn J Cancer Res 88, 363-8.
20. Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Jr., Saeed, Z. A., and Malaty, H. M. (1992). Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116, 705-8.
21. Group, T. E. S. (1993). An international association between Helicobacter pylori infection and gastric cancer. Lancet 341, 1359-62.
22. Hirayama, F., Takagi, S., Iwao, E., Yokoyama, Y., Haga, K., and Hanada, S. (1999a). Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 34, 450-4.
23. Hirayama, F., Takagi, S., Yokoyama, Y., Iwao, E., and Ikeda, Y. (1996). Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol 31 Suppl 9, 24-8.
24. Hirayama, Y., Wakazono, K., Yamamoto, M., Kitano, M., Tatematsu, M., Nagao, M., Sugimura, T., and Ushijima, T. (1999b). Rare mutations of p53, Ki-ras, and beta-catenin genes and absence of K-sam and c-erbB-2 amplification in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach cancers. Mol Carcinog 25, 42-7.
25. Honda, S., Fujioka, T., Tokieda, M., Satoh, R., Nishizono, A., and Nasu, M. (1998). Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58, 4255-9.
26. Hu, P. J., Li, Y. Y., Zhou, M. H., Chen, M. H., Du, G. G., Huang, B. J., Mitchell, H. M., and Hazell, S. L. (1995). Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 36, 198-202.
27. Huang, J. Q., Sridhar, S., Chen, Y., and Hunt, R. H. (1998). Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114, 1169-79.
28. IARC, L. (1994). Schistosomes, liver flukes and Helicobacter pylori. IARC Mono Eval Carcinogenic Risks Humans 61, 1-241.
29. Inada, K., Nakanishi, H., Fujimitsu, Y., Shimizu, N., Ichinose, M., Miki, K., Nakamura, S., and Tatematsu, M. (1997). Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol Int 47, 831-41.
30. Ishii, Y., Rex, M., Scotting, P. J., and Yasugi, S. (1998). Region-specific expression of chicken Sox2 in the developing gut and lung epithelium: regulation by epithelial-mesenchymal interactions. Dev Dyn 213, 464-75.
31. Japanese Gastric Cancer Association (1998). Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1, 10-24.
32. Joossens, J. V., Hill, M. J., Elliott, P., Stamler, R., Lesaffre, E., Dyer, A., Nichols, R., and Kesteloot, H. (1996). Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTER-SALT Cooperative Research Group. Int J Epidemiol 25, 494-504.
33. Karita, M., Kouchiyama, T., Okita, K., and Nakazawa, T. (1991). New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am J Gastroenterol 86, 1596-603.
34. Karita, M., Li, Q., Cantero, D., and Okita, K. (1994). Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. Am J Gastroenterol 89, 208-13.
35. Kato, S., Tsukamoto, T., Mizoshita, T., Tanaka, H., Kumagai, T., Ota, H., Katsuyama, T., Asaka, M., and Tatematsu, M. (2006). High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer 119, 1158-66.
36. Kawachi, H., Takizawa, T., Eishi, Y., Shimizu, S., Kumagai, J., Funata, N., and Koike, M. (2003). Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol 199, 436-46.
37. Kawachi, T., Kogure, K., Tanaka, N., Tokunaga, A., and Sugimura, T. (1974). Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharidases with "Tes-Tape". J Natl Cancer Inst 53, 19-30.
38. Kono, S., and Hirohata, T. (1996). Nutrition and stomach cancer. Cancer Causes Control 7, 41-55.
39. Koseki, K., Takizawa, T., Koike, M., Ito, M., Nihei, Z., and Sugihara, K. (2000). Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 89, 724-32.
40. Krakowka, S., Morgan, D. R., Kraft, W. G., and Leunk, R. D. (1987). Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 55, 2789-96.
41. Kuipers, E. J., Uyterlinde, A. M., Pena, A. S., Roosendaal, R., Pals, G., Nelis, G. F., Festen, H. P., and Meuwissen, S. G. (1995). Long-term sequelae of Helicobacter pylori gastritis. Lancet 345, 1525-8.
42. Kurihara, M., Shirakabe, H., Murakami, T., Yasui, A., and Izumi, T. (1974). A new method for producing adenocarcinomas in the stomach of dogs with N-ethyl-N′-nitro-N-nitrosoguanidine. Gann 65, 163-77.
43. Labenz, J., Blum, A. L., Bayerdorffer, E., Meining, A., Stolte, M., and Borsch, G. (1997). Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112, 1442-7.
44. Lauren, P. (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64, 31-49.
45. Lee, A., Fox, J. G., Otto, G., and Murphy, J. (1990). A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 99, 1315-23.
46. Lu, J., Imamura, K., Nomura, S., Mafune, K., Nakajima, A., Kadowaki, T., Kubota, N., Terauchi, Y., Ishii, G., Ochiai, A., Esumi, H., and Kaminishi, M. (2005). Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res 65, 4769-74.
47. Magari, H., Shimizu, Y., Inada, K. I., Enomoto, S., Tomeki, T., Yanaoka, K., Tamai, H., Arii, K., Nakata, H., Oka, M., Utsunomiya, H., Tsutsumi, Y., Tsukamoto, T., Tatematsu, M., and Ichinose, M. (2005). Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils. Biochem Biophys Res Commun 334, 606-12.
48. Malaty, H. M., El-Kasabany, A., Graham, D. Y., Miller, C. C., Reddy, S. G., Srinivasan, S. R., Yamaoka, Y., and Berenson, G. S. (2002). Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359, 931-5.
49. Mallo, G. V., Rechreche, H., Frigerio, J. M., Rocha, D., Zweibaum, A., Lacasa, M., Jordan, B. R., Dusetti, N. J., Dagorn, J. C., and Iovanna, J. L. (1997). Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 74, 35-44.
50. Marchetti, M., Arico, B., Burroni, D., Figura, N., Rappuoli, R., and Ghiara, P. (1995). Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267, 1655-8.
51. Marshall, B. J., and Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-1315.
52. Matsukura, N., Suzuki, K., Kawachi, T., Aoyagi, M., Sugimura, T., Kitaoka, H., Numajiri, H., Shirota, A., Itabashi, M., and Hirota, T. (1980). Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst 65, 231-40.
53. Mizoshita, T., Inada, K., Tsukamoto, T., Kodera, Y., Yamamura, Y., Hirai, T., Kato, T., Joh, T., Itoh, M., and Tatematsu, M. (2001). Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa-with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 4, 185-91.
54. Mizoshita, T., Inada, K., Tsukamoto, T., Nozaki, K., Joh, T., Itoh, M., Yamamura, Y., Ushijima, T., Nakamura, S., and Tatematsu, M. (2004a). Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol 130, 29-36.
55. Mizoshita, T., Tsukamoto, T., Inada, K., Ogasawara, N., Hirata, A., Kato, S., Joh, T., Itoh, M., Yamamura, Y., and Tatematsu, M. (2004b). Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 54, 392-400.
56. Mizoshita, T., Tsukamoto, T., Nakanishi, H., Inada, K., Ogasawara, N., Joh, T., Itoh, M., Yamamura, Y., and Tatematsu, M. (2003). Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 129, 727-34.
57. Mizoshita, T., Tsukamoto, T., Takenaka, Y., Cao, X., Kato, S., Kaminishi, M., and Tatematsu, M. (2006). Gastric and intestinal phenotypes and histogenesis of advanced glandular stomach cancers in carcinogen-treated, Helicobacter pylori-infected Mongolian gerbils. Cancer Sci 97, 38-44.
58. Mori, K. (1967). Carcinoma of the glandular stomach of mice by instillation of 4-nitroquinoline 1-oxide. Gann 58, 389-93.
59. Mori, K., and Ohta, A. (1967). Carcinoma of the glandular stomach of mice induced by 4-hydroxyaminoquinoline 1-oxide. Gann 58, 551-4.
60. Morson, B. C. (1955). Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 9, 377-85.
61. Mutoh, H., Hakamata, Y., Sato, K., Eda, A., Yanaka, I., Honda, S., Osawa, H., Kaneko, Y., and Sugano, K. (2002). Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 294, 470-9.
62. Naef, A. P., Savary, M., and Ozzello, L. (1975). Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 70, 826-35.
63. Nakamura, K., Sugano, H., and Takagi, K. (1968). Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 59, 251-8.
64. Nam, K. T., Hahm, K. B., Oh, S. Y., Yeo, M., Han, S. U., Ahn, B., Kim, Y. B., Kang, J. S., Jang, D. D., Yang, K. H., and Kim, D. Y. (2004). the selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori associated gastric cancer development in a mouse model. Clin Cancer Res 10, 8105-13.
65. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I., and Blaser, M. J. (1991). Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325, 1132-6.
66. Nozaki, K., Shimizu, N., Ikehara, Y., Inoue, M., Tsukamoto, T., Inada, K., Tanaka, H., Kumagai, T., Kaminishi, M., and Tatematsu, M. (2003). Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 94, 235-9.
67. Nozaki, K., Shimizu, N., Inada, K., Tsukamoto, T., Inoue, M., Kumagai, T., Sugiyama, A., Mizoshita, T., Kaminishi, M., and Tatematsu, M. (2002a). Synergistic promoting effects of Helicobacter pylori infection and highsalt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 93, 1083-9.
68. Nozaki, K., Shimizu, N., Tsukamoto, T., Inada, K., Cao, X., Ikehara, Y., Kaminishi, M., Sugiyama, A., and Tatematsu, M. (2002b). Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori infected Mongolian gerbils on eradication. Jpn. J. Cancer Res. 93, 374-81.
69. Ohgaki, H., Fukuda, M., Tohma, Y., Huang, H., Stoica, G., Tatematsu, M., and Donehower, L. A. (2000). Effect of intragastric application of N-methylnitrosourea in p53 knockout mice. Mol Carcinog 28, 97-101.
70. Oshima, H., Oshima, M., Inaba, K., and Taketo, M. M. (2004). Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. Embo J 23, 1669-78.
71. Oshima, M., Oshima, H., Matsunaga, A., and Taketo, M. M. (2005). Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 65, 9147-51.
72. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325, 1127-31.
73. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich, N., Vogelman, J. H., and Friedman, G. D. (1994). Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330, 1267-71.
74. Radin, M. J., Eaton, K. A., Krakowka, S., Morgan, D. R., Lee, A., Otto, G., and Fox, J. (1990). Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun 58, 2606-12.
75. Rusch, H. P., Baumann, C.A., Maison G. L. (1940). Pruduction of internal tumors with chemical carcinogens. Arch Pathol 29, 8-19.
76. Sakai, H., Eishi, Y., Li, X. L., Akiyama, Y., Miyake, S., Takizawa, T., Konishi, N., Tatematsu, M., Koike, M., and Yuasa, Y. (2004). PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 53, 323-30.
77. Shimizu, N., Ikehara, Y., Inada, K., Nakanishi, H., Tsukamoto, T., Nozaki, K., Kaminishi, M., Kuramoto, S., Sugiyama, A., Katsuyama, T., and Tatematsu, M. (2000). Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 60, 1512-4.
78. Shimizu, N., Inada, K., Nakanishi, H., Tsukamoto, T., Ikehara, Y., Kaminishi, M., Kuramoto, S., Sugiyama, A., Katsuyama, T., and Tatematsu, M. (1999a). Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20, 669-76.
79. Shimizu, N., Inada, K. I., Tsukamoto, T., Nakanishi, H., Ikehara, Y., Yoshikawa, A., Kaminishi, M., Kuramoto, S., and Tatematsu, M. (1999b). New animal model of glandular stomach carcinogenesis in Mongolian gerbils infected with Helicobacter pylori and treated with a chemical carcinogen. J Gastroenterol 34 Suppl 11, 61-6.
80. Silberg, D. G., Furth, E. E., Taylor, J. K., Schuck, T., Chiou, T., and Traber, P. G. (1997). CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113, 478-86.
81. Silberg, D. G., Sullivan, J., Kang, E., Swain, G. P., Moffett, J., Sund, N. J., Sackett, S. D., and Kaestner, K. H. (2002). Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122, 689-96.
82. Silberg, D. G., Swain, G. P., Suh, E. R., and Traber, P. G. (2000). Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119, 961-71.
83. Soubeyran, P., Andre, F., Lissitzky, J. C., Mallo, G. V., Moucadel, V., Roccabianca, M., Rechreche, H., Marvaldi, J., Dikic, I., Dagorn, J. C., and Iovanna, J. L. (1999). Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology 117, 1326-38.
84. Stemmermann, G. N., and Hayashi, T. (1968). Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst 41, 627-34.
85. Stewart, H. L., and Snell, K. C. (1958). Histopathogenesis of carcinoma induced in the glandular stomach of C57BL mice by the intramural injection of 20-methylcholanthrene. J Natl Cancer Inst 21, 999-1035.
86. Sugano, H., Nakamura, K., and Kato, Y. (1982). Pathological studies of human gastric cancer. Acta Pathol Jpn 32 Suppl 2, 329-47.
87. Sugimura, T., and Fujimura, S. (1967). Tumour production in glandular stomach of rat by N-methyl-N′-nitro-N-nitrosoguanidine. Nature 216, 943-4.
88. Sugimura, T., and Kawachi, T. (1976). [Experimental gastric cancer (author's transl)]. Leber Magen Darm 6, 80-90.
89. Sugimura, T., and Kawachi, T. (1973). Methods in Cancer Research, ed. by H. Busch, Academic Press Inc., New York. Vol. VII, pp. 245-308.
90. Sugimura, T., Tanaka, N., Kawachi, T., Kogure, K., and Fujimura, S. (1971). Production of stomach cancer in dogs by N-methyl-N′-nitro-N- nitrosoguanidine. Gann 62, 67.
91. Sugiyama, A., Maruta, F., Ikeno, T., Ishida, K., Kawasaki, S., Katsuyama, T., Shimizu, N., and Tatematsu, M. (1998). Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58, 2067-9.
92. Tajima, K., and Tominaga, S. (1985). Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res 76, 705-16.
93. Tajima, Y., Shimoda, T., Nakanishi, Y., Yokoyama, N., Tanaka, T., Shimizu, K., Saito, T., Kawamura, M., Kusano, M., and Kumagai, K. (2001). Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 61, 212-20.
94. Takahashi, M. (1970). Effect of alkylbenzenesulfonate as a vehicle for 4-nitroquinoline 1-oxide on gastric carcinogenesis in rats. Gann 61, 27-33.
95. Takahashi, M., Nishikawa, A., Furukawa, F., Enami, T., Hasegawa, T., and Hayashi, Y. (1994). Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with N-methyl-N′-nitro- N-nitrosoguanidine. Carcinogenesis 15, 1429-32.
96. Takahashi, M., and Sato, H. (1969). Effect of 4-nitroquinoline 1-oxide with alkylbenzenesulfonate on gastric carcinogenesis in rats. Gann Monogr 8, 241-261.
97. Tatematsu, M., Aoki, T., Inoue, T., Mutai, M., Furihata, C., and Ito, N. (1988). Coefficient induction of pepsinogen 1-decreased pyloric glands and gastric cancers in five different strains of rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 9, 495-8.
98. Tatematsu, M., Furihata, C., Hirose, M., Shirai, T., and Ito, N. (1977). Changes in pepsinogen isozymes in stomach cancers induced in Wistar rats by N-methyl-N′-nitro-N-nitrosoguanidine and in transplantable gastric carcinoma (SG2B). J Natl Cancer Inst 58, 1709-16.
99. Tatematsu, M., Furihata, C., Katsuyama, T., Hasegawa, R., Nakanowatari, J., Saito, D., Takahashi, M., Matsushima, T., and Ito, N. (1983). Independent induction of intestinal metaplasia and gastric cancer in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res 43, 1335-41.
100. Tatematsu, M., Furihata, C., Katsuyama, T., Mera, Y., Inoue, T., Matsushima, T., and Ito, N. (1987). Immunohistochemical demonstration of pyloric gland-type cells with low-pepsinogen isozyme 1 in preneoplastic and neoplastic tissues of rat stomachs treated with N-methyl-Ń-nitro-N-nitrosoguanidine. J Natl Cancer Inst 78, 771-7.
101. Tatematsu, M., Furihata, C., Katsuyama, T., Miki, K., Honda, H., Konishi, Y., and Ito, N. (1986a). Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 46, 4866-72.
102. Tatematsu, M., Furihata, C., Mera, Y., Shirai, T., Matsushima, T., and Ito, N. (1986b). Immunohistochemical demonstration of induction of pyloric glands with low pepsinogen 1 (Pg 1) content in rat stomach by N-methyl-N′-nitro-N-nitrosoguanidine. Jpn J Cancer Res 77, 238-43.
103. Tatematsu, M., Hasegawa, R., Ogawa, K., Kato, T., Ichinose, M., Miki, K., and Ito, N. (1992a). Histogenesis of human stomach cancers based on assessment of differentiation. J Clin Gastroenterol 14 Suppl 1, S1-7.
104. Tatematsu, M., Ichinose, M., Miki, K., Hasegawa, R., Kato, T., and Ito, N. (1990a). Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 40, 494-504.
105. Tatematsu, M., Ichinose, M., Tsukada, S., Kakei, N., Takahashi, S., Ogawa, K., Hirose, M., Furihata, C., Miki, K., Kurokawa, K., et al. (1993a). DNA methylation of the pepsinogen 1 gene during rat glandular stomach carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine or catechol. Carcinogenesis 14, 1415-9.
106. Tatematsu, M., Katsuyama, T., Fukushima, S., Takahashi, M., Shirai, T., Ito, N., and Nasu, T. (1980a). Mucin histochemistry by paradoxical concanavalin A staining in experimental gastric cancers induced in Wistar rats by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline 1-oxide. J Natl Cancer Inst 64, 835-43.
107. Tatematsu, M., Katsuyama, T., Furihata, C., Fukushima, S., Shirai, T., Kato, T., and Ito, N. (1990b). Cellular differentiation and histogenesis of rat glandular stomach cancers. Jpn J Cancer Res 81, 760-7.
108. Tatematsu, M., Katsuyama, T., Furihata, C., Tsuda, H., and Ito, N. (1984). Stable intestinal phenotypic expression of gastric and small intestinal tumor cells induced by N-methyl-N′-nitro-N-nitrosoguanidine or methylnitrosourea in rats. Gann 75, 957-65.
109. Tatematsu, M., Ogawa, K., Hoshiya, T., Shichino, Y., Kato, T., Imaida, K., and Ito, N. (1992b). Induction of adenocarcinomas in the glandular stomach of BALB/c mice treated with N-methyl-N-nitrosourea. Jpn J Cancer Res 83, 915-8.
110. Tatematsu, M., Saito, D., Furihata, C., Miyata, Y., Nakatsuka, T., Ito, N., and Sugimura, T. (1980b). Initial DNA damage and heritable permanent change in pepsinogen isoenzyme pattern in the pyloric mucosae of rats after short-term administration of N-methyl-N′-nitro-N-nitrosoguanidine. J Natl Cancer Inst 64, 775-81.
111. Tatematsu, M., Takahashi, M., Fukushima, S., Hananouchi, M., and Shirai, T. (1975). Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst 55, 101-6.
112. Tatematsu, M., Tsukamoto, T., and Inada, K. (2003). Stem cells and gastric cancer - Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 94, 135-141.
113. Tatematsu, M., Yamamoto, M., Iwata, H., Fukami, H., Yuasa, H., Tezuka, N., Masui, T., and Nakanishi, H. (1993b). Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water. Jpn J Cancer Res 84, 1258-64.
114. Tatematsu, M., Yamamoto, M., Shimizu, N., Yoshikawa, A., Fukami, H., Kaminishi, M., Oohara, T., Sugiyama, A., and Ikeno, T. (1998). Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N′-nitro-N- nitrosoguanidine in drinking water. Jpn J Cancer Res 89, 97-104.
115. Tsugane, S. (2005). Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 96, 1-6.
116. Tsugane, S., Tsuda, M., Gey, F., and Watanabe, S. (1992). Cross-sectional study with multiple measurements of biological markers for assessing stomach cancer risks at the population level. Environ Health Perspect 98, 207-10.
117. Tsukamoto, T., Hirata, A., and Tatematsu, M. (2005). Susceptibility of heterozygous and nullizygous p53 knockout mice to chemical carcinogens: tissue dependence and role of p53 gene mutations. J. Toxicol. Pathol. 18, 121-34.
118. Tsukamoto, T., Inada, K., Tanaka, H., Mizoshita, T., Mihara, M., Ushijima, T., Yamamura, Y., Nakamura, S., and Tatematsu, M. (2004). Down regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: Inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 130, 135-145.
119. Tsukamoto, T., Yamamoto, M., Ogasawara, N., Ushijima, T., Nomoto, T., Fujita, H., Matsushima, T., Nozaki, K., Cao, X., and Tatematsu, M. (2003). beta-Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas. Cancer Sci. 94, 1046-51.
120. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R. J. (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345, 784-9.
121. Warren, J. R., and Marshall, B. (1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i, 1273-5.
122. Watanabe, T., Tada, M., Nagai, H., Sasaki, S., and Nakao, M. (1998). Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115, 642-8.
123. Wilson, R. H., De Eds, F., and Cox, Jr., A. J. (1941). The toxicity and carcinogenic activity of 2-acetaminofluorene. Cancer Res 1, 595-608.
124. Yamachika, T., Inada, K., Fujimitsu, Y., Nakamura, S., Yamamura, Y., Kitou, T., Itzkowitz, S. H., Werther, J. L., Miki, K., and Tatematsu, M. (1997). Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 431, 103-10.
125. Yamamoto, M., Furihata, C., Fujimitsu, Y., Imai, T., Inada, K., Nakanishi, H., and Tatematsu, M. (1997). Dose-dependent induction of both pepsinogen-altered pyloric glands and adenocarcinomas in the glandular stomach of C3H mice treated with N-methyl-N-nitrosourea. Jpn J Cancer Res 88, 238-44.
126. Yamamoto, M., Furihata, C., Ogiu, T., Tsukamoto, T., Inada, K., Hirano, K., and Tatematsu, M. (2002). Independent variation in susceptibilities of six different mouse strains to induction of pepsinogen-altered pyloric glands and gastric tumor intestinalization by N-methyl-N-nitrosourea. Cancer Lett 179, 121-32.
127. Yamamoto, M., Tsukamoto, T., Sakai, H., Shirai, N., Ohgaki, H., Furihata, C., Donehower, L. A., Yoshida, K., and Tatematsu, M. (2000). p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis. Carcinogenesis 21, 1891-27.
128. Yasugi, S. (2000). Epithelial cell differentiation during stomach development. Hum Cell 13, 177-84.
129. Yoshikawa, A., Inada Ki, K., Yamachika, T., Shimizu, N., Kaminishi, M., and Tatematsu, M. (1998). Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1, 134-141.
130. You, W. C., Blot, W. J., Li, J. Y., Chang, Y. S., Jin, M. L., Kneller, R., Zhang, L., Han, Z. X., Zeng, X. R., Liu, W. D., et al. (1993). Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 53, 1317-21.
131. Yuasa, H., Hirano, K., Kodama, H., Nakanishi, H., Imai, T., Tsuda, H., Imaida, K., and Tatematsu, M. (1994). Immunohistochemical demonstration of intestinal-type alkaline phosphatase in stomach tumors induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. Jpn J Cancer Res 85, 897-903.
132. Yuasa, H., Inada, K., Watanabe, H., and Tatematsu, M. (2002). A phenotypic shift from gastric-intestinal to solely intestinal cell types in intestinal metaplasia in rat stomach following treatment with X-rays. J Toxicol Pathol 15, 85-93.
133. Yuasa, Y. (2003). Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3, 592-600.